Last Updated: September 3, 2026

FLUNISOLIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Flunisolide patents expire, and what generic alternatives are available?

Flunisolide is a drug marketed by Apotex, Bausch, Riconpharma Llc, and Rising. and is included in four NDAs.

The generic ingredient in FLUNISOLIDE is flunisolide. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the flunisolide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Flunisolide

A generic version of FLUNISOLIDE was approved as flunisolide by BAUSCH on February 20th, 2002.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for FLUNISOLIDE?
  • What are the global sales for FLUNISOLIDE?
  • What is Average Wholesale Price for FLUNISOLIDE?
Recent Clinical Trials for FLUNISOLIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of LouisvilleN/A
Meda PharmaceuticalsN/A
GlaxoSmithKlinePhase 3

See all FLUNISOLIDE clinical trials

Pharmacology for FLUNISOLIDE

US Patents and Regulatory Information for FLUNISOLIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex FLUNISOLIDE flunisolide SPRAY, METERED;NASAL 077436-001 Aug 9, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Rising FLUNISOLIDE flunisolide SPRAY, METERED;NASAL 077704-001 Aug 3, 2006 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Bausch FLUNISOLIDE flunisolide SPRAY, METERED;NASAL 074805-001 Feb 20, 2002 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.